ATE346096T1 - G-csf tpo fusionsproteine - Google Patents

G-csf tpo fusionsproteine

Info

Publication number
ATE346096T1
ATE346096T1 AT96912262T AT96912262T ATE346096T1 AT E346096 T1 ATE346096 T1 AT E346096T1 AT 96912262 T AT96912262 T AT 96912262T AT 96912262 T AT96912262 T AT 96912262T AT E346096 T1 ATE346096 T1 AT E346096T1
Authority
AT
Austria
Prior art keywords
polypeptide
activity
csf
fusion polypeptide
fusion proteins
Prior art date
Application number
AT96912262T
Other languages
English (en)
Inventor
Haruhiko Yokoi
Yukimasa Shiotsu
Noboru Konishi
Hideharu Anazawa
Tatsuya Tamaoki
Motoo Yamasaki
Yoko Terasaki
Kazuhisa Uchida
Kinya Yamashita
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE346096T1 publication Critical patent/ATE346096T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/524—Thrombopoietin, i.e. C-MPL ligand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT96912262T 1995-04-26 1996-04-26 G-csf tpo fusionsproteine ATE346096T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10262595 1995-04-26

Publications (1)

Publication Number Publication Date
ATE346096T1 true ATE346096T1 (de) 2006-12-15

Family

ID=14332430

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96912262T ATE346096T1 (de) 1995-04-26 1996-04-26 G-csf tpo fusionsproteine

Country Status (8)

Country Link
EP (1) EP0783003B1 (de)
JP (1) JP3763846B2 (de)
AT (1) ATE346096T1 (de)
AU (1) AU705064B2 (de)
CA (1) CA2194070A1 (de)
DE (1) DE69636714T2 (de)
ES (1) ES2276401T3 (de)
WO (1) WO1996034016A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869451A (en) * 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6251864B1 (en) 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6066318A (en) * 1995-10-05 2000-05-23 G.D. Searle & Co. Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
AU2002212108A1 (en) * 2000-11-02 2002-05-15 Maxygen Aps Single-chain multimeric polypeptides
MXPA05003057A (es) 2002-09-18 2006-04-18 Johnson & Johnson Metodos para aumentar la produccion de celulas madre hematopoyeticas y plaquetas.
US20050079155A1 (en) * 2003-03-20 2005-04-14 Xencor, Inc. Generating protein pro-drugs using reversible PPG linkages
US7723295B2 (en) 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
KR20120078742A (ko) 2003-08-28 2012-07-10 오르토-맥네일 파마슈티칼, 인코퍼레이티드 수용체에 결합하는 펩티드 및 화합물
WO2006041088A1 (ja) * 2004-10-12 2006-04-20 Tissue Targeting Japan Inc. 脳移行性骨髄前駆細胞
RU2385875C2 (ru) * 2008-04-24 2010-04-10 Ибмед Холдингс Лимитед Пептид, обладающий ростостимулирующей активностью гранулоцитарного колониестимулирующего фактора человека

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0796558B2 (ja) * 1988-03-31 1995-10-18 協和醗酵工業株式会社 修飾ポリペプチド
AU5355790A (en) * 1989-04-19 1990-11-16 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
JPH04103599A (ja) * 1990-08-22 1992-04-06 Toray Ind Inc 融合ポリペプチド
CA2089553C (en) * 1990-08-29 2000-06-27 Paul Schendel Multidomain hematopoiesis stimulators
JPH05502463A (ja) * 1990-09-28 1993-04-28 オーソ・フアーマシユーチカル・コーポレーシヨン ハイブリツド成長因子

Also Published As

Publication number Publication date
CA2194070A1 (en) 1996-10-31
WO1996034016A1 (en) 1996-10-31
EP0783003A1 (de) 1997-07-09
ES2276401T3 (es) 2007-06-16
EP0783003A4 (de) 1998-01-07
AU5514796A (en) 1996-11-18
DE69636714T2 (de) 2007-10-18
EP0783003B1 (de) 2006-11-22
DE69636714D1 (de) 2007-01-04
JP3763846B2 (ja) 2006-04-05
AU705064B2 (en) 1999-05-13

Similar Documents

Publication Publication Date Title
YU27999A (sh) Preparati ob fuzionog proteina i postupci
NO990560L (no) Kjemisk modifiserte polypeptider
BR9301944A (pt) Derivado de proteina c,molecula de dna recombinante,celula hospedeira e formulacao farmaceutica
EP1454138A4 (de) Immunocytokine mit modulierter selektivität
DE69131580D1 (de) GDF-1 und UOG1 Proteine
DK1200479T3 (da) Multiple cytokin-antistof-komplekser
EE05201B1 (et) Glkoslitud interferoon-beeta, selle kasutamine ja seda sisaldav farmatseutiline kompositsioon, meetod interferoon-beeta-1a aktiivsuse pikendamiseks ja leiutisekohase valgu valmistamiseks
DE69931507D1 (de) Interferon-beta fusionsproteine und deren verwendungen
IT8367525A0 (it) Proteina ibrida comprendente frammenti proteici collegati da legami peptidici e relativo gene di fusione composizione contenente tale proteina
DE69942231D1 (de) Ortspezifische duale pegylation von proteine
EP0783527A4 (de) Cathepsin-02-protease
ATE171596T1 (de) Neue gegen phtiraptera aktive bcillus thuringiensis isolate
ATE346096T1 (de) G-csf tpo fusionsproteine
DE69837085D1 (de) Crsp-proteine (cystein-reiche, sekretierte proteine), die dafür kodierenden nukleinsäuren und ihre verwendungen
ATE364703T1 (de) Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
FI954657L (fi) Biologisesti aktiivisia polypeptidifuusiodimeereja
IL80562A0 (en) Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it
EP1558729A4 (de) Schnell abgebaute reporter-fusionsproteine
AU1431188A (en) Dihydropyridine - pyridinium salt-type redox amino acids and peptides containing them
EP0676413A3 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung.
NO894573L (no) Rekombinante interleukin-2 hybridproteiner.
DE69534738D1 (de) Leukocyten-aktivierender Faktor
WO2000049039A3 (de) Glucose-dehydrogenase-fusionsproteine und ihre verwendung in expressionssystemen
FI970230L (fi) Menetelmä proteiinien, kuten yhdistelmä-DNA-hirudiinin tai -epidermaalisen kasvutekijän laskostamiseksi
SE8800981D0 (sv) A recombinant fusion protein, its use and a recombinant vector

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties